Molina Healthcare, Inc. (NYSE:MOH) Sees Significant Decrease in Short Interest

Molina Healthcare, Inc. (NYSE:MOH) was the target of a large decline in short interest in April. As of April 15th, there was short interest totalling 956,100 shares, a decline of 16.9% from the March 31st total of 1,150,000 shares. Based on an average daily trading volume, of 400,900 shares, the short-interest ratio is presently 2.4 days. Currently, 1.7% of the company’s stock are sold short.

Insider Activity at Molina Healthcare

In other news, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, CFO Mark Lowell Keim sold 15,000 shares of the stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the transaction, the chief financial officer now owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Richard M. Schapiro sold 1,000 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total transaction of $401,050.00. Following the completion of the sale, the director now directly owns 11,207 shares in the company, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. Insiders sold 16,711 shares of company stock valued at $6,472,517 in the last three months. Corporate insiders own 1.11% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Annis Gardner Whiting Capital Advisors LLC bought a new stake in shares of Molina Healthcare in the 3rd quarter valued at $30,000. McIlrath & Eck LLC bought a new position in Molina Healthcare in the 4th quarter worth about $34,000. VisionPoint Advisory Group LLC increased its holdings in shares of Molina Healthcare by 105.6% in the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after purchasing an additional 57 shares during the period. Raleigh Capital Management Inc. raised its stake in Molina Healthcare by 40.4% in the third quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock valued at $41,000 after purchasing an additional 36 shares in the last quarter. Finally, Principal Securities Inc. bought a new stake in Molina Healthcare during the fourth quarter worth about $42,000. 98.50% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on MOH shares. Truist Financial increased their price objective on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a report on Tuesday, February 20th. Barclays lowered their price objective on Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating for the company in a research report on Thursday, April 25th. Wells Fargo & Company reduced their price objective on Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating for the company in a research note on Monday. StockNews.com downgraded shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 8th. Finally, TD Cowen dropped their price objective on shares of Molina Healthcare from $453.00 to $412.00 and set a “buy” rating for the company in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, Molina Healthcare has a consensus rating of “Hold” and an average price target of $398.55.

Molina Healthcare Trading Down 0.5 %

Shares of NYSE MOH traded down $1.79 during midday trading on Tuesday, hitting $342.10. The stock had a trading volume of 390,458 shares, compared to its average volume of 402,951. The company’s 50-day simple moving average is $389.18 and its 200 day simple moving average is $372.38. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49. The firm has a market cap of $20.05 billion, a P/E ratio of 18.55, a price-to-earnings-growth ratio of 0.96 and a beta of 0.47. Molina Healthcare has a fifty-two week low of $266.35 and a fifty-two week high of $423.92.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.46 by $0.27. The business had revenue of $9.93 billion for the quarter, compared to analyst estimates of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. Molina Healthcare’s revenue was up 21.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.81 earnings per share. Research analysts anticipate that Molina Healthcare will post 23.62 EPS for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.